by Laura Rinaldi | May 29, 2026 | Blog, Why We Invested
By: Scott Button, Partner at Clarevia Ventures RiverMark Medical recently announced a $20 million Series D financing led by Andera Partners to develop the FloStent™ System, an investigational device designed to offer a non-surgical, reversible, office-based treatment...
by Kayla Liederbach | May 9, 2025 | Why We Invested
Pictured above: Panel discussion with John Neis, Lloyd Smith, Lance Fors, James Dahlberg, Kevin Conroy, and Maneesh Arora at Exact Sciences on Dec 2, 2024. Three decades ago, Clarevia (VI) made a bold move by backing Third Wave Technologies, a...
